VTR Stock Analysis — Ventas
Sector: Healthcare REIT
AI Verdict
At 104.4x next year's earnings, you're paying a premium the numbers don't yet support—unless Ventas delivers on its massive growth promise, the risk of a sharp pullback is high.
Competitive Moat
Ventas owns and operates a diversified portfolio of senior housing and healthcare properties, benefiting from long-term demographic tailwinds as the population ages. Its scale and relationships with top healthcare operators create high switching costs and stable tenant demand.
Summary
Ventas is notable for its aggressive forward EPS growth forecast of 60.4%, paired with a sky-high 104.4x forward P/E.
Where It Stands
With a 47.24% 1-year return, RSI of 73.6 (overbought), and a forward P/E of 104.4x versus the healthcare sector median of 22x, the stock is trading at a steep premium after a major run.
Key Metrics
- RSI: 73.6 — Overbought
- Trailing P/E: 167.4x
- Forward P/E: 104.4x
- PEG Ratio: 2.69
- Earnings Growth: +0.6%
- Revenue Growth: +0.2%
- Market Cap: $44.9B
- Dividend Yield: 0.02%
- 1-Year Return: 47.24%
- 52-Week High: $94.60
- 52-Week Low: $62.06
Analyst Consensus
22 Buy · 4 Hold · 0 Sell (26 analysts)
Bull Case
Analysts expect EPS to jump 60.4% next year, which could justify some premium if the growth materializes.
Bear Case
If the P/E multiple contracts from 104.4x toward the sector median of 22x, shares could lose over 75% even if earnings hit targets.
Catalyst to Watch
Quarterly earnings that confirm or challenge the 60.4% EPS growth trajectory will determine if the valuation holds.